Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunotherapy in Melanoma Patients With Brain Metastases Treated With Steroids
NCT03563729Phase 2Recruiting
- Start
- Jun 2018
- Primary completion
- Jun 2024
- Modality
- Immune Checkpoint Inhibitors, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pembrolizumab, ipilimumab, nivolumab in melanoma. Started Jun 2018; status: recruiting.
02
Drugs
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT03563729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03563729.